AssayIndex
Reports by quarter

Reports submitted in 2026-Q1

Rule AX-R12 added. Dataset v2 schema published. Median purity for the quarter is 99.22 % area, n=806. Read the 2026-Q1 state-of-the-index report →

806 records21 pagesmedian on this page 99.00 %updated 30 Jul 2026
0408012092.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=096.25–96.50 %: n=096.50–96.75 %: n=096.75–97.00 %: n=297.00–97.25 %: n=497.25–97.50 %: n=697.50–97.75 %: n=1397.75–98.00 %: n=2198.00–98.25 %: n=4098.25–98.50 %: n=5798.50–98.75 %: n=8598.75–99.00 %: n=7999.00–99.25 %: n=11399.25–99.50 %: n=11899.50–99.75 %: n=12899.75–100.00 %: n=140median 99.22 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2026-Q1. n=806, median 99.22 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-041719TirzepatideTFSTFS-{CAT}-1353Janoshik2026-Q198.574.63106.2Buyer-sourced0PASS
AX-2026-042074TirzepatideHYBHYB-2509-J7103Janoshik2026-Q198.313.9398.4Buyer-sourced0PASS
AX-2026-042609ARA-290HJHJ-2508-C7084Janoshik2026-Q199.484.94—Buyer-sourced0PASS
AX-2026-042334TirzepatideTFCTFC-2508-L2482Janoshik2026-Q198.141.3498.2Buyer-sourced1FAIL
AX-2026-041625SelankFGPFGP-2511-D8133Medutest2026-Q199.766.3898.2Buyer-sourced0PASS
AX-2026-041343CJC-1295 with DACWWBWWB-2508-V3100Kestrel2026-Q199.935.3899.1Buyer-sourced0PASS
AX-2026-043559LiraglutideSIGSIG-2508-6459VendorInvestigate2026-Q197.665.90—Buyer-sourced0PASS
AX-2026-042632TirzepatideSWBSWB-2601-V7010PeptideMeter2026-Q198.694.4191.5Buyer-sourced0PASS
AX-2026-043458GHRP-2BCHBCH-2508-M4472Janoshik2026-Q198.775.43—Buyer-sourced0FAIL
AX-2026-041729TB-500TFSTFS-{CAT}-9979Janoshik2026-Q199.933.62106.3Buyer-sourced1FAIL
AX-2026-041711TirzepatideTFSTFS-{CAT}-1353Janoshik2026-Q198.444.8297.5Buyer-sourced0PASS
AX-2026-043338GonadorelinCPCCPC-2508-B2206Janoshik2026-Q198.844.00—Buyer-sourced0PASS
AX-2026-042407RetatrutideHomopeptideHOMO-2601-J3763VendorInvestigate2026-Q198.994.9590.8Buyer-sourced0PASS
AX-2026-041869RetatrutideSinoPepSNP-2603-G4042Nordanalyt2026-Q197.625.52101.1Buyer-sourced1MARGINAL
AX-2026-043325IpamorelinCPCCPC-2508-Y1913PeptideMeter2026-Q198.115.61—Buyer-sourced1FAIL
AX-2026-042845TirzepatideGGPepsGGPE-2510-L2662Janoshik2026-Q198.513.8594.0Buyer-sourced0PASS
AX-2026-042688SemaxERPERP-2512-G9157VendorInvestigate2026-Q199.098.90102.4Buyer-sourced0PASS
AX-2026-041710TirzepatideTFSTFS-{CAT}-1353Janoshik2026-Q199.064.25102.7Buyer-sourced0PASS
AX-2026-041694EpitalonTFSTFS-{CAT}-9792Medutest2026-Q199.939.6094.3Buyer-sourced0FAIL
AX-2026-041564SemaglutideQSCQSC-2602-G7336Janoshik2026-Q198.585.27—Buyer-sourced0PASS
AX-2026-043073ExenatideKPKP-2511-W5891Nordanalyt2026-Q198.973.52—Supplier-supplied0PASS
AX-2026-043027IpamorelinKPKP-2512-X4745Janoshik2026-Q199.012.9189.6Supplier-supplied1MARGINAL
AX-2026-043197ExenatideGL BiochemGLBI-2509-A7833PeptideMeter2026-Q198.733.70105.7Buyer-sourced0PASS
AX-2026-042405RetatrutideHomopeptideHOMO-2601-J3763Janoshik2026-Q198.894.0299.9Buyer-sourced0PASS
AX-2026-042179BPC-157JEEPJEEP-2509-G9040Janoshik2026-Q199.273.73—Buyer-sourced0PASS
AX-2026-042060TriptorelinHYBHYB-2512-B7307Janoshik2026-Q199.463.8694.9Buyer-sourced0PASS
AX-2026-043489MOTS-cBCHBCH-2601-U5146PeptideMeter2026-Q198.105.61—Buyer-sourced0PASS
AX-2026-043398MOTS-cWXTWXT-2512-K3109Medutest2026-Q197.722.33102.3Buyer-sourced0FAIL
AX-2026-042158SemaxJEEPJEEP-2512-U8593Janoshik2026-Q199.597.17—Laboratory-retained0PASS
AX-2026-042102SemaxJEEPJEEP-2602-C8195Janoshik2026-Q199.517.43—Buyer-sourced0FAIL
AX-2026-041317ARA-290WWBWWB-2511-S3009Janoshik2026-Q199.934.08—Buyer-sourced0PASS
AX-2026-041233L-Glutathione (reduced)WWBWWB-2602-U1840Janoshik2026-Q199.489.29104.7Buyer-sourced0PASS
AX-2026-043479IpamorelinBCHBCH-2510-P4971VendorInvestigate2026-Q199.313.71102.2Buyer-sourced0PASS
AX-2026-043272L-Glutathione (reduced)CPCCPC-2602-D1499Janoshik2026-Q198.508.64102.5Supplier-supplied0PASS
AX-2026-042364SemaxHomopeptideHOMO-2602-S3200Nordanalyt2026-Q199.589.14—Buyer-sourced0PASS
AX-2026-042068TriptorelinHYBHYB-2512-B7307Janoshik2026-Q199.384.4088.8Buyer-sourced1MARGINAL
AX-2026-042788RetatrutideGGPepsGGPE-2510-R1919Janoshik2026-Q199.402.60—Supplier-supplied0PASS
AX-2026-042443SemaglutideHomopeptideHOMO-2511-C4492PeptideMeter2026-Q198.715.06—Buyer-sourced0PASS
AX-2026-043664TB-500PPGPPG-2512-D8068Janoshik2026-Q199.243.87100.6Buyer-sourced0PASS
AX-2026-042787RetatrutideGGPepsGGPE-2510-R1919Janoshik2026-Q199.123.3092.9Supplier-supplied0PASS